GO
Loading...

Osiris Therapeutics Inc

  • A Biotech Short-Seller Responds to Critics Tuesday, 17 Jul 2012 | 12:24 PM ET

    Short selling is never going to be a wildly popular investing practice, but it is perfectly legal and essential for the proper function of the capital markets. I asked a biotech short seller for his thoughts on why long investors seem so hostile to short sellers and whether this animosity will compel short sellers to be even more reluctant to voice their opinions publicly.

  • Stocks Close Mixed After Fed Extends 'Twist' Wednesday, 20 Jun 2012 | 6:56 PM ET

    Stocks wobbled out of the gate Wednesday, with traders hesitant to make any strong commitments head of the afternoon Federal Reserve policy decision.

  • Stocks to Watch: ONXX, BAC, IDCC & More Monday, 18 Jun 2012 | 12:45 PM ET

    Take a look at some of Monday's midday movers:

  • Stem Cells Sell Tuesday, 17 Feb 2009 | 1:45 PM ET

    Attendance at the 4th Annual Stem Cell Summit is up, by about 50 percent, no less, over last year. All day long privately-held and publicly-traded companies are presenting to around 250 investors.

  • Stocks On The Move: Osiris, Valero... Friday, 4 Jan 2008 | 6:54 PM ET

    Following are the week’s biggest winners and losers. Find out why shares of Osiris Therapeutics (OSIR) and Humana (HUM) popped while Valero (VLO) and Macy's (M) dropped.

  • Mad Mail Thursday, 12 Apr 2007 | 2:55 PM ET

    Cramer takes your questions on Lundin Mining, Dean Foods and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.